A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

By afschroeder • August 31, 2025

Deane KD, Striebich CC, Feser ML, O'Dell JR, James JA, Sparks JA, Davis JM, Graf J, McMahon MA, Solow EB, Forbess L, Tiliakos A, Schiopu E, Danila MI, Horowitz DL, Kay J, Strickland CD, Guthridge JM, Arriens C, Grossman JM, Demoruelle MK, Bemis EA, Frazer-Abel A, Fleischer CL, Fox DA, Mikuls TR, Greenleaf M, York K, Walker S, Keyes-Elstein L, Byron M, Fedler J, Goldmuntz EA, Holers VM. A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis. Arthritis Rheumatol. 2025 Aug 29. doi: 10.1002/art.43366. Epub ahead of print. PMID: 40884017.

Tags: Publications, Rheumatology

Ambient AI Scribes in Clinical Practice: A Randomized Trial

Lukac PJ, Turner W, Vangala S, Chin AT, Khalili J, Shih YT, Sarkisian C, Cheng EM, Mafi JN. Ambient AI Scribes in Clinical Practice: A[...]

North American and European practices for opioid-sparing and opioid-free anaesthesia: a cross-sectional survey

Gricourt Y, Boulos NM, Daoulas Y, Grogan T, Alexander B, Mezzarobba M, Cuvillon P, Pogatzki-Zahn EM, Beloeil H, Cannesson M, Forget P, Joosten A. North[...]

Amara Yad Image: The 3-Chamber View-Inferomedial Segment

Shivkumar K, Mori S. Amara Yad Image: The 3-Chamber View-Inferomedial Segment. J Am Coll Cardiol. 2026 Jan 6;87(1):117-119. doi: 10.1016/j.jacc.2025.10.037. PMID: 41498475.